Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 08:02 am Sale | 2022-12-31 | 13G | Talaris Therapeutics, Inc. TALS | Citadel Advisors LLC | 352,217 8.400% | -28,947 (-7.59%) | Filing History |
| 2023-02-14 08:02 am Sale | 2022-12-31 | 13G | Vera Therapeutics, Inc. VERA | Citadel Advisors LLC | 1,991,553 7.200% | -50,867 (-2.49%) | Filing History |
| 2023-02-14 08:02 am Purchase | 2022-12-31 | 13G | Vigil Neuroscience, Inc. VIGL | Citadel Advisors LLC | 2,163,916 6.100% | 55,196 (+2.62%) | Filing History |
| 2023-02-14 08:02 am Sale | 2022-12-31 | 13G | Ventyx Biosciences, Inc. VTYX | Citadel Advisors LLC | 3,788,795 6.700% | -102,278 (-2.63%) | Filing History |
| 2023-02-14 08:02 am Purchase | 2022-12-31 | 13G | Aura Biosciences, Inc. AURA | Citadel Advisors LLC | 2,737,053 7.400% | 421,951 (+18.23%) | Filing History |
| 2023-02-14 08:02 am Purchase | 2022-12-31 | 13G | Artemis Strategic Investment Corporation ARTE | Citadel Advisors LLC | 1,621,525 8.100% | 442,720 (+37.56%) | Filing History |
| 2023-02-14 08:02 am Sale | 2022-12-31 | 13G | Aerovate Therapeutics, Inc. AVTE | Citadel Advisors LLC | 44,628 6.400% | -1,014 (-2.22%) | Filing History |
| 2023-02-14 08:02 am Sale | 2022-12-31 | 13G | Acrivon Therapeutics, Inc. Common Stock ACRV | Citadel Advisors LLC | 1,634,149 7.800% | -488 (-0.03%) | Filing History |
| 2023-02-14 08:02 am Sale | 2022-12-31 | 13G | ARYA Sciences Acquisition Corp V ARYE | Citadel Advisors LLC | 1,062,378 6.900% | -334 (-0.03%) | Filing History |
| 2023-02-14 08:02 am Sale | 2022-12-31 | 13G | Bolt Biotherapeutics, Inc. BOLT | Citadel Advisors LLC | 137,610 7.300% | -3,013 (-2.14%) | Filing History |
| 2023-02-14 08:02 am Sale | 2022-12-31 | 13G | Catcha Investment Corp CHAA | Citadel Advisors LLC | 2,204,889 7.400% | -337,950 (-13.29%) | Filing History |
| 2023-02-14 08:02 am Purchase | 2022-12-31 | 13G | Decibel Therapeutics, Inc. DBTX | Citadel Advisors LLC | 1,863,411 7.500% | 35,484 (+1.94%) | Filing History |
| 2023-02-14 08:02 am Sale | 2022-12-31 | 13G | Elliott Opportunity II Corp. EOCW | Citadel Advisors LLC | 3,134,685 5.100% | -666,237 (-17.53%) | Filing History |
| 2023-02-14 08:02 am Sale | 2022-12-31 | 13G | Conyers Park III Acquisition Corp. CPAA | Citadel Advisors LLC | 1,877,136 5.300% | -748,695 (-28.51%) | Filing History |
| 2023-02-14 07:41 am Sale | 2022-12-31 | 13G | Austerlitz Acquisition Corporation I AUS | Citadel Advisors LLC | 0 0.000% | -5,677,718 (Position Closed) | Filing History |
| 2023-02-14 07:41 am Unchanged | 2022-12-31 | 13G | AEA-BRIDGES IMPACT CORP UNIT 1 IMPXU | Citadel Advisors LLC | 0 0.000% | 0 (Unchanged) | Filing History |
| 2023-02-14 07:41 am Sale | 2022-12-31 | 13G | Jiya Acquisition Corp. JYAC | Citadel Advisors LLC | 0 0.000% | -784,610 (Position Closed) | Filing History |
| 2023-02-14 07:41 am Sale | 2022-12-31 | 13G | Lerer Hippeau Acquisition Corp. LHAA | Citadel Advisors LLC | 0 0.000% | -1,292,422 (Position Closed) | Filing History |
| 2023-02-14 07:41 am Sale | 2022-12-31 | 13G | SOAR Technology Acquisition Corp. FLYA | Citadel Advisors LLC | 0 0.000% | -1,349,037 (Position Closed) | Filing History |
| 2023-02-14 07:41 am Sale | 2022-12-31 | 13G | NightDragon Acquisition Corp. NDAC | Citadel Advisors LLC | 0 0.000% | -1,942,976 (Position Closed) | Filing |